COc1cc(CC2C(=O)OCC2[C@@H](OC(C)=O)c2ccc3c(c2)OCO3)c(Br)c(OC)c1OC
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?